These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 3134124

  • 1. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration.
    Pogach LM, Lee Y, Gould S, Giglio W, Huang HF.
    Cancer Res; 1988 Aug 01; 48(15):4354-60. PubMed ID: 3134124
    [Abstract] [Full Text] [Related]

  • 2. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.
    Ward JA, Robinson J, Furr BJ, Shalet SM, Morris ID.
    Cancer Res; 1990 Feb 01; 50(3):568-74. PubMed ID: 2137024
    [Abstract] [Full Text] [Related]

  • 3. Protection from procarbazine-induced damage of spermatogenesis in the rat by androgen.
    Delic JI, Bush C, Peckham MJ.
    Cancer Res; 1986 Apr 01; 46(4 Pt 2):1909-14. PubMed ID: 3081260
    [Abstract] [Full Text] [Related]

  • 4. GnRH-A induced arrest of spermiogenesis in rats is associated with altered androgen binding protein distribution in the testis and epididymis.
    Huang HF, Pogach L, Giglio W, Nathan E, Seebode J.
    J Androl; 1992 Apr 01; 13(2):153-9. PubMed ID: 1597399
    [Abstract] [Full Text] [Related]

  • 5. Time dependence for the protective effect of androgen from procarbazine-induced damage to rat spermatogenesis.
    Delic JI, Harwood JR, Stanley JA.
    Cancer Res; 1987 Mar 01; 47(5):1344-7. PubMed ID: 3102044
    [Abstract] [Full Text] [Related]

  • 6. Protection by steroid contraceptives against procarbazine-induced sterility and genotoxicity in male rats.
    Velez de la Calle JF, Jégou B.
    Cancer Res; 1990 Feb 15; 50(4):1308-15. PubMed ID: 2137028
    [Abstract] [Full Text] [Related]

  • 7. Hormone treatment after irradiation stimulates recovery of rat spermatogenesis from surviving spermatogonia.
    Meistrich ML, Kangasniemi M.
    J Androl; 1997 Feb 15; 18(1):80-7. PubMed ID: 9089071
    [Abstract] [Full Text] [Related]

  • 8. Maintenance of spermiogenesis by exogenous testosterone in rats treated with a GnRH antagonist: relationship with androgen-binding protein status.
    Pogach L, Giglio W, Nathan E, Huang HF.
    J Reprod Fertil; 1993 Jul 15; 98(2):415-22. PubMed ID: 8410806
    [Abstract] [Full Text] [Related]

  • 9. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr 15; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 10. Rapid protection of rat spermatogenic stem cells against procarbazine by treatment with a gonadotropin-releasing hormone antagonist (Nal-Glu) and an antiandrogen (flutamide).
    Kangasniemi M, Wilson G, Parchuri N, Huhtaniemi I, Meistrich ML.
    Endocrinology; 1995 Jul 15; 136(7):2881-8. PubMed ID: 7789313
    [Abstract] [Full Text] [Related]

  • 11. Suppression of growth hormone does not affect ongoing spermatogenesis in rats.
    Awoniyi CA, Veeramachaneni DN, Roberts D, Tucker KE, Chandrashekar V, Schlaff WD.
    J Androl; 1999 Jul 15; 20(1):102-8. PubMed ID: 10100480
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gonadotropin-releasing hormone analogs stimulate and testosterone inhibits the recovery of spermatogenesis in irradiated rats.
    Shetty G, Wilson G, Huhtaniemi I, Shuttlesworth GA, Reissmann T, Meistrich ML.
    Endocrinology; 2000 May 15; 141(5):1735-45. PubMed ID: 10803584
    [Abstract] [Full Text] [Related]

  • 15. Hormonal treatment after cytotoxic therapy stimulates recovery of spermatogenesis.
    Meistrich ML, Wilson G, Huhtaniemi I.
    Cancer Res; 1999 Aug 01; 59(15):3557-60. PubMed ID: 10446960
    [Abstract] [Full Text] [Related]

  • 16. Quantitative maintenance of spermatogenesis in cyclosporine-treated rats by exogenous administration of testosterone propionate.
    Seethalakshmi L, Flores C, Carboni AA, Menon M.
    J Androl; 1990 Aug 01; 11(6):491-7. PubMed ID: 2128298
    [Abstract] [Full Text] [Related]

  • 17. Acute and chronic effects of cisplatinum upon testicular function in the rat.
    Huang HF, Pogach LM, Nathan E, Giglio W.
    J Androl; 1990 Aug 01; 11(5):436-45. PubMed ID: 2254177
    [Abstract] [Full Text] [Related]

  • 18. Follicle-stimulating hormone is required for the initial phase of spermatogenic restoration in adult rats following gonadotropin suppression.
    Meachem SJ, Wreford NG, Stanton PG, Robertson DM, McLachlan RI.
    J Androl; 1998 Aug 01; 19(6):725-35. PubMed ID: 9876024
    [Abstract] [Full Text] [Related]

  • 19. Hypoprolactinemia does not prevent restoration of normal spermatogenesis in gonadotropin-suppressed, testosterone-replaced rats.
    Awoniji CA, Roberts D, Chandrashekar V, Hurst BS, Tucker KE, Schlaff WD.
    J Androl; 1996 Aug 01; 17(1):35-40. PubMed ID: 8833739
    [Abstract] [Full Text] [Related]

  • 20. The effects of recombinant FSH on testosterone-induced spermatogenesis in gonadotrophin-deficient (hpg) mice.
    Singh J, Handelsman DJ.
    J Androl; 1996 Aug 01; 17(4):382-93. PubMed ID: 8889701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.